Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 4 Malignant Glioma of Brain (Disorder)”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Testing effectiveness (Phase 2)Looking for participantsNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Not applicableLooking for participantsNCT06118723
What this trial is testing

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Who this might be right for
GlioblastomaHigh-grade GliomaGlioblastoma, IDH-wildtype+9 more
Jasper Gerritsen 784
Early research (Phase 1)Study completedNCT01985256
What this trial is testing

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 17
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Testing effectiveness (Phase 2)Study completedNCT02986178
What this trial is testing

Lerapolturev in Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Istari Oncology, Inc. 121
Early research (Phase 1)Study completedNCT02313272
What this trial is testing

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Who this might be right for
Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Study completedNCT01740258
What this trial is testing

Bevacizumab Beyond Progression (BBP)

Who this might be right for
Malignant GliomaGrade 4 Malignant GliomaGlioblastoma+1 more
Duke University 68
Early research (Phase 1)Study completedNCT03072134
What this trial is testing

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Who this might be right for
GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+5 more
Northwestern University 12
Early research (Phase 1)Looking for participantsNCT07541781
What this trial is testing

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Who this might be right for
GliomaGlioblastomaRecurrent Glioma+2 more
Kailin Yang, MD, PhD 45
Testing effectiveness (Phase 2)Study completedNCT01738646
What this trial is testing

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Who this might be right for
Recurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor
Duke University 48
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Early research (Phase 1)Ended earlyNCT04327011
What this trial is testing

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Who this might be right for
Glioblastoma MultiformeAstrocytomaGliomas, Malignant
Tocagen Inc. 65
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644312
What this trial is testing

Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaWHO Grade 3 Glioma+2 more
Nationwide Children's Hospital 12
Early research (Phase 1)Study completedNCT01470794
What this trial is testing

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 58
Early research (Phase 1)Study completedNCT00612651
What this trial is testing

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Who this might be right for
GliosarcomaGlioblastomaAnaplastic Astrocytoma
Duke University 37
Early research (Phase 1)Study completedNCT02903069
What this trial is testing

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Who this might be right for
GlioblastomaMalignant Glioma
Celgene 66
Testing effectiveness (Phase 2)Study completedNCT00752323
What this trial is testing

Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Andrew Sloan, MD 73
Next Page